The Global Sarcopenia Treatment Market size was valued at around USD 3 billion in 2024 and is projected to reach USD 3.9 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 4% during the forecast period, i.e., 2025-30.             

Global Sarcopenia Treatment Market Driver:

Increasing Global Aging Population – The Global Sarcopenia Treatment Market is majorly driven by the growing global aging population. The number of people more than 65 years old globally is projected to increase by double, rising from 761 million in 2021 to at least 1.6 billion in 2050. Due to this demographic trade sarcopenia, a situation that affects a massive percentage of older adults, and other age-associated illnesses are becoming usual. People begin losing nearly 3 to 8 percent of their muscular mass every ten years after the age of 30. Throughout their lives, maximum males will lose roughly 30% of their muscular mass. Sarcopenia has been mentioned to influence up to 15% of people aged between 60 to 70 years and as much as 50% of people over 80 years of age. This lack of muscle is a serious difficulty for older populations because it can result in increased frailty, disability, and a high chance of falls and fractures.

Thus, effective sarcopenia treatment options are becoming more important as the population ages to preserve independence, enhance mobility, and decrease medical charges related to the situation's complications. Developing information on the sarcopenia affects elderly people is also demanding interventions like medicine, physical remedies, and dietary supplements.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/sarcopenia-treatment-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/sarcopenia-treatment-market.html

Global Sarcopenia Treatment Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Treatment Type
• Protein Supplements - Market Size & Forecast 2020-2030F, USD Million
• Vitamin B12 Supplements - Market Size & Forecast 2020-2030F, USD Million
• Vitamin D and Calcium Supplements - Market Size & Forecast 2020-2030F, USD Million
• By Diagnostic Method
• Biochemical Tests - Market Size & Forecast 2020-2030F, USD Million
• Imaging Techniques - Market Size & Forecast 2020-2030F, USD Million
• Functional Assessments - Market Size & Forecast 2020-2030F, USD Million
• Others - Market Size & Forecast 2020-2030F, USD Million
• By Distribution Channel
• Hospital Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
• Retail Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
• Online Pharmacies Source - Market Size & Forecast 2020-2030F, USD Million
• Other - Market Size & Forecast 2020-2030F, USD Million
• By Region
• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Pfizer Inc., Yeast Zydus Cadila, Ltd, Angel Yeast, Makers Nutrition LLC, Metabolic Technologies Inc., Metagenics LLC, Haleon Group of Companies, Abbott Laboratories, Nestlé SA, Eli Lilly, Sanofi Inc., Novartis AG, Amway Corporation, Bayer AG, and Others

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/sarcopenia-treatment-market.html

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release